Drawing for ARBORETUM

USPTO serial 98788847

ARBORETUM

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
CLYBURN, CARLA DIONNE
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with ARBORETUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Betsy Wang Lee

Betsy Wang Lee Orrick, Herrington & Sutcliffe LLP2050 Main Street, Suite 1100IP Prosecution DepartmentIrvine, CA 92614-8255

Goods and services

ClassDescriptionStatusFirst use
035Business consulting in the field of clinical trials, namely, clinical data management on behalf of medical, biopharmaceutical, and biotechnology companies to assist them with clinical research, clinical trials, and applications for drug approval; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business consulting in the field of clinical trials, namely, providing information management services; database management of a biobank containing de-identified human genetic and biological samples; computerized database managementACTIVE—
036Financial services, namely, raising capital for clinical trial purposes; financial services, namely, raising money for the clinical trials of others; investment consultation for clinical trialsACTIVE—
042Database design and development; biomedical database design and development; development and maintenance of cloud-based software for collecting, organizing, cataloguing, and accessing biological samples for medical and scientific research purposes; development and maintenance of cloud-based software for facilitating clinical trials; providing temporary use of non-downloadable computer software for creating a searchable database of biomedical data and information; providing temporary use of non-downloadable computer software for purposes of collecting and managing clinical data for the purpose of clinical research, clinical trials, and applications for drug approval; providing temporary use of non-downloadable computer software for management and compilation of computerized databases in the field of clinical trials for business purposes; consulting services for others in the field of design, planning, and implementation project management of clinical trials; providing temporary use of non-downloadable computer software for creating and managing a biobank containing de-identified human genetic and biological samples for the purpose of creating and maintaining a resource for medical and scientific research purposes; providing an on-line searchable database featuring biomedical data; biomedical research services; providing temporary use of non-downloadable computer software for the purpose of creating and maintaining a database of patient data for use in clinical trials; providing medical and scientific research information in the field of clinical trials; providing temporary use of non-downloadable computer software featuring technology to allow users to conduct bioinformatics analysis for medical, scientific, and clinical research purposes; providing temporary use of non-downloadable computer software for collecting, maintaining, and processing genomic and clinical data for medical and scientific research purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 7, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 6, 2026EX2GSOU EXTENSION 2 GRANTED—
Apr 6, 2026EXT2SOU EXTENSION 2 FILED—
Apr 6, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 25, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 25, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 2, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 2, 2025EX1GSOU EXTENSION 1 GRANTED—
Dec 2, 2025EXT1SOU EXTENSION 1 FILED—
Dec 2, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 25, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Nov 25, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 25, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 25, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 21, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 21, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 21, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 21, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 21, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 24, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 29, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 29, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 23, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 28, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 20, 2025DOCKASSIGNED TO EXAMINER—
Feb 5, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 7, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 7, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance